Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1,2020.
| FactSnippet No. 1,661,915 |
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1,2020.
| FactSnippet No. 1,661,915 |
Reshma Kewalramani is the first female CEO of a large US biotech company.
| FactSnippet No. 1,661,916 |
Reshma Kewalramani was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.
| FactSnippet No. 1,661,917 |
Reshma Kewalramani finished her internship and residency at the Massachusetts General Hospital and her fellowship in nephrology at the Massachusetts General Hospital and Brigham and Women's Hospital combined program.
| FactSnippet No. 1,661,918 |
Reshma Kewalramani graduated from the General Management Program at Harvard Business School in 2015.
| FactSnippet No. 1,661,919 |
Reshma Kewalramani was a physician at the Massachusetts Eye and Ear Infirmary and the Massachusetts Institute of Technology.
| FactSnippet No. 1,661,920 |
Reshma Kewalramani then entered the biopharma sector, working for Amgen for over 12 years, where she held leadership positions in research and development.
| FactSnippet No. 1,661,921 |
Reshma Kewalramani assumed the role of president and CEO on April 1,2020 and is a member of the Vertex Board of Directors.
| FactSnippet No. 1,661,922 |
Reshma Kewalramani is a member of the Massachusetts General Hospital Board of Trustees, the Biomedical Science Careers Program Board and the Boston University School of Medicine Dean's Advisory Board.
| FactSnippet No. 1,661,923 |
Reshma Kewalramani is a member of the board of directors of Ginkgo Bioworks, and was on the inaugural board of directors of the Kidney Health Initiative.
| FactSnippet No. 1,661,924 |
Reshma Kewalramani is a Fellow of the American Society of Nephrology and received board certification in Internal Medicine in 2001 and in Nephrology in 2003.
| FactSnippet No. 1,661,926 |
In 2020, Reshma Kewalramani was named to the inaugural Business Leaders List by Indiaspora, Business Insider's list of 10 people transforming health care, the PharmaVOICE 100 list of leaders in the life sciences, and Boston Business Journal's list of Women Who Mean Business.
| FactSnippet No. 1,661,927 |